Immunic, Inc.
IMUX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001280776
No open-market purchases or sales by Immunic, Inc. insiders were filed in the last 90 days; 56 institutions reported holding it in 13F filings for Q2 2026, worth $130.6M in total; no superinvestor holds it.
Q2 2021 vs. Q1 2021
How the institutions holding Immunic, Inc. changed between Q1 2021 and Q2 2021.
All holders in Q2 2021All holders in Q1 2021
| Measure | Q1 2021 | Q2 2021 | Change |
|---|---|---|---|
| Holders | 64 | 61 | −3 |
| Shares | 9.30M | 9.44M | +134.5K (+1.4%) |
| Value | $148.3M | $115.7M | −$32.6M (−22.0%) |
New holders (5)
Institutions that held Immunic, Inc. at the end of Q2 2021 but not at the end of Q1 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Rhumbline Advisers | 14,159 | $174.0K | 0.00% |
| Citadel Advisors LLC | 13,909 | $171.0K | 0.00% |
| Goldman Sachs Group Inc | 12,131 | $149.0K | 0.00% |
| Trexquant Investment LP | 10,674 | $131.0K | 0.01% |
| UBS Group AG | 3,621 | $44.0K | 0.00% |
Sold out (8)
Institutions that held Immunic, Inc. at the end of Q1 2021 and filed for Q2 2021 without it.
| Institution | Shares, Q1 2021 | Value, Q1 2021 |
|---|---|---|
| Point72 Asset Management, L.P. | 433,047 | $6.90M |
| Price T Rowe Associates Inc | 262,382 | $4.18M |
| TD Asset Management Inc | 32,628 | $520.0K |
| Susquehanna Fundamental Investments, LLC | 29,510 | $470.0K |
| Verition Fund Management LLC | 24,692 | $394.0K |
| ExodusPoint Capital Management, LP | 15,285 | $244.0K |
| Bank of Montreal | 473 | $7.00K |
| Cubist Systematic Strategies, LLC | 176 | $3.00K |